Next, in an effort to ascertain the impact of HLA variations on DLBCL prognosis, we used univariate and multivariate analyses to assess whether the presence of HLA-C*12, in conjunction with other parameters that have been found to affect DLBCL prognosis, could affect OS and PFS. Here, HLA-C is linked to diffuse large B-cell lymphoma.